Advanced Biomedical Research

The Effect of Levothyroxine on Serum Levels of Interleukin 10 and Interferon-gamma in Rat Model of Multiple Sclerosis

Document Type : Original Article

Authors

1 Department of Physiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Department of Anatomical Sciences, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: There is an increase in inflammatory and a reduction in anti-inflammatory cytokines in multiple sclerosis (MS). Considering the role of thyroid hormones in the development and regulation of both neural and immune systems, the aim of this study was to evaluate the effects of levothyroxine on serum concentrations of interleukin-10 (IL-10) and interferon gamma (IFN-γ) in animal models of MS. Materials and Methods: To induce demyelination in male Wistar rats, lysolecithin was injected into the optic chiasm. Then levothyroxine was injected intraperitoneally (20, 50, and 100 μg/kg) for 21 days. Serum levels of cytokines were measured by enzyme-linked immunosorbent assay at 7, 14, and 21 days after that. Results: The results showed that injection of lysolecithin to the optic chiasm only increased serum concentrations of IL-10 compared to the sham group (P < 0.05) at 7th day, but this increase was prevented by all doses of levothyroxine. IFN-γ was decreased significantly (P < 0.001) 21 days after. Comparing to the sham group at all sampling time and with respect to the MS group at the days 7 and 21, levothyroxine decreased serum concentrations of IFN-γ significantly. Conclusion: The results showed that thyroid hormones probably could produce protective effects against induced demyelination through affecting immune responses.

Keywords

1.
Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 2005;23:683-747.  Back to cited text no. 1
    
2.
Franklin RJ. Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 2002;3:705-14.  Back to cited text no. 2
    
3.
Stangel M, Hartung HP. Remyelinating strategies for the treatment of multiple sclerosis. Prog Neurobiol 2002;68:361-76.  Back to cited text no. 3
    
4.
Calzà L, Fernandez M, Giardino L. Cellular approaches to central nervous system remyelination stimulation: Thyroid hormone to promote myelin repair via endogenous stem and precursor cells. J Mol Endocrinol 2010;44:13-23.  Back to cited text no. 4
    
5.
Lachapelle F, Avellana-Adalid V, Nait-Oumesmar B, Baron-Van Evercooren A. Fibroblast growth factor-2 (FGF-2) and platelet-derived growth factor AB (PDGF AB) promote adult SVZ-derived oligodendrogenesis in vivo. Mol Cell Neurosci 2002;20:390-403.  Back to cited text no. 5
    
6.
Préau L, Fini JB, Morvan-Dubois G, Demeneix B. Thyroid hormone signaling during early neurogenesis and its significance as a vulnerable window for endocrine disruption. Biochim Biophys Acta 2015;1849:112-21.  Back to cited text no. 6
    
7.
Remaud S, Gothié JD, Morvan-Dubois G, Demeneix BA. Thyroid hormone signaling and adult neurogenesis in mammals. Front Endocrinol (Lausanne) 2014;5:62.  Back to cited text no. 7
    
8.
Dugas JC, Ibrahim A, Barres BA. The T3-induced gene KLF9 regulates oligodendrocyte differentiation and myelin regeneration. Mol Cell Neurosci 2012;50:45-57.  Back to cited text no. 8
    
9.
Høglund RA, Maghazachi AA. Multiple sclerosis and the role of immune cells. World J Exp Med 2014;4:27-37.  Back to cited text no. 9
    
10.
Poyraz T, Idiman E, Uysal S, Iyilikci L, Ozakbas S, Coskuner Poyraz E, et al. The cooling effect on proinflammatory cytokines interferon-gamma, tumor necrosis factor-alpha, and nitric oxide in patients with multiple sclerosis. ISRN Neurol 2013;2013:964572.  Back to cited text no. 10
    
11.
Langer-Gould A, Gupta R, Huang S, Hagan A, Atkuri K, Leimpeter AD, et al. Interferon-gamma-producing T cells, pregnancy, and postpartum relapses of multiple sclerosis. Arch Neurol 2010;67:51-7.  Back to cited text no. 11
    
12.
Ireland SJ, Monson NL, Davis LS. Seeking balance: Potentiation and inhibition of multiple sclerosis autoimmune responses by IL-6 and IL-10. Cytokine 2015;73:236-44.  Back to cited text no. 12
    
13.
Niino M, Fukazawa T, Miyazaki Y, Takahashi E, Minami N, Amino I, et al. Suppression of IL-10 production by calcitriol in patients with multiple sclerosis. J Neuroimmunol 2014;270:86-94.  Back to cited text no. 13
    
14.
Moghaddasi M, Javanmard SH, Reisi P, Tajadini M, Taati M. The effect of regular exercise on antioxidant enzyme activities and lipid peroxidation levels in both hippocampi after occluding one carotid in rat. J Physiol Sci 2014;64:325-32.  Back to cited text no. 14
    
15.
Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 5th ed. San Diego: Academic Press; 2005. p. 36.  Back to cited text no. 15
    
16.
Asghari AA, Azarnia M, Mirnajafi-Zadeh J, Javan M. Adenosine A1 receptor agonist, N6-cyclohexyladenosine, protects myelin and induces remyelination in an experimental model of rat optic chiasm demyelination; electrophysiological and histopathological studies. J Neurol Sci 2013;325:22-8.  Back to cited text no. 16
    
17.
Wu CY, Liu B, Wang HL, Ruan DY. Levothyroxine rescues the lead-induced hypothyroidism and impairment of long-term potentiation in hippocampal CA1 region of the developmental rats. Toxicol Appl Pharmacol 2011;256:191-7.  Back to cited text no. 17
    
18.
Lees JR, Cross AH. A little stress is good: IFN-gamma, demyelination, and multiple sclerosis. J Clin Invest 2007;117:297-9.  Back to cited text no. 18
    
19.
Panitch HS, Hirsch RL, Schindler J, Johnson KP. Treatment of multiple sclerosis with gamma interferon: Exacerbations associated with activation of the immune system. Neurology 1987;37:1097-102.  Back to cited text no. 19
    
20.
Pusic AD, Kraig RP. Phasic treatment with interferon gamma stimulates release of exosomes that protect against spreading depression. J Interferon Cytokine Res 2015;35:795-807.  Back to cited text no. 20
    
21.
Shen W, Ren X, Zhu J, Xu Y, Lin J, Li Y, et al. Discovery of a new structural class of competitive hDHODH inhibitors with in vitro and in vivo anti-inflammatory, immunosuppressive effects. Eur J Pharmacol 2016;791:205-12.  Back to cited text no. 21
    
22.
Marchant A, Bruyns C, Vandenabeele P, Ducarme M, Gérard C, Delvaux A, et al. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol 1994;24:1167-71.  Back to cited text no. 22
    
23.
Ozenci V, Kouwenhoven M, Huang YM, Xiao B, Kivisäkk P, Fredrikson S, et al. Multiple sclerosis: Levels of interleukin-10-secreting blood mononuclear cells are low in untreated patients but augmented during interferon-beta-1b treatment. Scand J Immunol 1999;49:554-61.  Back to cited text no. 23
    
24.
Nakahara J, Maeda M, Aiso S, Suzuki N. Current concepts in multiple sclerosis: Autoimmunity versus oligodendrogliopathy. Clin Rev Allergy Immunol 2012;42:26-34.  Back to cited text no. 24
    
25.
De Vito P, Balducci V, Leone S, Percario Z, Mangino G, Davis PJ, et al. Nongenomic effects of thyroid hormones on the immune system cells: New targets, old players. Steroids 2012;77:988-95.  Back to cited text no. 25
    
26.
Klecha AJ, Barreiro Arcos ML, Frick L, Genaro AM, Cremaschi G. Immune-endocrine interactions in autoimmune thyroid diseases. Neuroimmunomodulation 2008;15:68-75.  Back to cited text no. 26
    
27.
De Vito P, Incerpi S, Pedersen JZ, Luly P, Davis FB, Davis PJ. Thyroid hormones as modulators of immune activities at the cellular level. Thyroid 2011;21:879-90.  Back to cited text no. 27
    
28.
Yao C, Zhang J, Wang L, Guo Y, Tian Z. Inhibitory effects of thyroxine on cytokine production by T cells in mice. Int Immunopharmacol 2007;7:1747-54.  Back to cited text no. 28
Advanced Biomedical Research
Volume 2017, september
September 2017
Pages 1-4